Table 2 Demographic characterization of FHS participants.

From: Lymphocyte activation gene-3-associated protein networks are associated with HDL-cholesterol and mortality in the Trans-omics for Precision Medicine program

Participant characteristics

FHS

No. subjects

1913

Women

1024 (53.5)

Age, years

55 (47,63)

HDL-C, mg/dl

48 (39,59) (n = 1907)

LDL-C, mg/dl

125 [104, 146] (n = 1855)

Triglycerides, mg/dl

121 [85, 179] (n = 1913)

BMI, kg/m2

26.7 [24.0, 29.9] (n = 1910)

fasting glucose

95 [89, 104] (n = 1897)

Systolic blood pressure (SBP), mmHg

124 [113, 138] (n = 1913)

Diastolic blood pressure (DBP), mmHg

74 [68,81] (n = 1913)

Current smoke (yes/no)

370 (19.3) (n = 1912)

Lipid medication (yes/no)

142 (7.4) (n = 1913)

LAG3 protein levels (Ex 5), RFU

4764 [3635, 6204] (n = 1913)

Presence of calcium indicator (yes/no)

NA

Agatston calcium score, phantom-adjusted

NA

Common carotid intimal-medical thickness (mm)

NA

Internal carotid intimal-medical thickness (mm)

NA

Ankle-brachial index (ABI) (Gen 3)

1.23 [1.18, 1.28] (n = 2609)

Myocardial infarction (MI) (yes/no)

97 (5.1)

Follow-up time (days)

7039 days

  1. Data are presented as n (%) for binary measures or median [Interquartile range (IQR)] for continuous measure. N = number of participants in each variable. Exam = FHS proteomics data for Examination 5.